Diagnostic kits in parasitology: Which controls?;Kit per la diagnostica parassitologica: Quali controlli?

Parassitologia

Volumn 46, Issue 1-2, 2004, Pages 145-149

  Rossi, P ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PARASITE ANTIBODY;

BIOTECHNOLOGY; CALIBRATION; CONFERENCE PAPER; DIAGNOSTIC TEST; HEALTH SURVEY; MARKETING; MEDICAL PRACTICE; MEDICAL RESEARCH; PARASITOLOGY; PARASITOSIS; PREDICTION; RELIABILITY; SAFETY; SENSITIVITY AND SPECIFICITY; TOXOPLASMOSIS; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION; ANALYTICAL EQUIPMENT; ANIMAL; CLINICAL TRIAL; ECONOMICS; EUROPE; FOOD AND DRUG ADMINISTRATION; HUMAN; LEGAL ASPECT; METHODOLOGY; REVIEW; STANDARD; UNITED STATES;

TOXOPLASMA;

ANIMALS; CLINICAL TRIALS; EUROPE; HUMANS; MARKETING; PARASITIC DISEASES; PARASITOLOGY; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WORLD HEALTH ORGANIZATION;

EID: 4844225928     PISSN: 00482951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Derouin F, Garin YJ, Buffard C, Berthelot F, Petithory JC (1994). Multicenter study of toxoplasma serology using various commercial ELISA reagents. Work Group Toxoplasmosis of the National Agency for Quality Control in Parasitology. Bulletin of the World Health Organization 72: 249-256.
2. Gamble HR, Pozio E, Bruschi F, Nöckler K, Kapel CMO, Gajadhar AA (2004). International Commission on Trichinellosis: recommendations on the use of serological tests for the detection of Trichinella infetion in animals and man. Parasite 11: 3-13.
3. Hansen GA, Lyng J, Petersen E (1994). Calibration of a replacement preparation for the second international standard for anti-Toxoplasma serum, human. World Health Organization BS/94 1761.
4. Petithory JC, Reiter-Owona I, Berthelot F, Milgram M, De Loye J, Petersen E (1996). Performance of European Laboratories testing Serum Samples for Toxoplasma gondii. European Journal of Clinical Microbiology and Infectious Diseases 15: 45-49.
5. Small PM, Perkins MD (2000). More rigour needed in trials of new diagnostic agents for tuberculosis. The Lancet 356: 1048-1049.
6. The Sexually Transmitted Diseases Diagnostics Initiative (SDI). Report (2003). Diagnostics Evaluation Series No. 1. TDR/SDI/DE/03.1.
7. Troullier P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N (2002). Drug development for neglected diseases: a deficient market and a public-health policy failure. The Lancet 359: 2188-2194.
8. World Health Organization, Expert Committee on Biological Standardization (1976). An international reference reagent of anti-Echinococcus human serum.WHO Technical Report Series, No. 594: 17.
9. World Health Organization, Expert Committee on Biological Standardization (1990). Guidelines for the preparation, characterization and establishment of international and other standards and reference reagents for biological substances. WHO Technical Report Series, No. 800, Annex 4: 181-214.
10. World Health Organization, Expert Committee on Biological Standardization (1995). Regulation and licensing of biological products in countries with newly developing regulatory authorities. WHO Technical Report Series, No. 858, Annex 1: 21-35.